National Health Investors (NHI)
(Delayed Data from NYSE)
$79.23 USD
+0.97 (1.24%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $79.23 0.00 (0.00%) 6:14 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NHI 79.23 +0.97(1.24%)
Will NHI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NHI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NHI
National Health Investors (NHI) Tops Q2 FFO Estimates
Service Properties (SVC) Q2 FFO and Revenues Beat Estimates
NHI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xenia Hotels & Resorts (XHR) Tops Q2 FFO and Revenue Estimates
STRW or NHI: Which Is the Better Value Stock Right Now?
National Health Investors (NHI) Q1 FFO and Revenues Beat Estimates
Other News for NHI
20 Day Moving Average Support appears for NHI after 0.64% move
Is NHI set to rally? 20 Day Moving Average Support shows up after sliding 1.41%
Replace Welltower With National Health Investors
180 Bullish Setup appears for NHI after 0.74% move
Is NHI preparing to trend higher? 1,2,3 Pullback Bullish shows up after declining 1.02%